<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="ijms-20-00642-t001" orientation="portrait" position="float" class="table-wrap">
 <object-id pub-id-type="pii" class="object-id">ijms-20-00642-t001_Table 1</object-id>
 <label class="label">Table 1</label>
 <caption class="caption">
  <p class="p">In vivo studies of cyclodextrin inclusion complexes.</p>
 </caption>
 <table frame="hsides" rules="groups" class="table">
  <thead class="thead">
   <tr class="tr">
    <th colspan="7" align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" class="th">Biological Activity In Vivo</th>
   </tr>
   <tr class="tr">
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th">CD Type</th>
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th">Complexed Substance</th>
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th">Animal</th>
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th">Dose</th>
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th">Activity</th>
    <th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th">Improved Characteristics</th>
    <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="th">References</th>
   </tr>
  </thead>
  <tbody class="tbody">
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-CD</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-caryophyllene</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Mice (S)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">10 or 20 mg/kg</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Analgesic</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">All doses tested produced a significant reduction in mechanical hyperalgesia and a significant increase in muscle withdrawal thresholds, without producing any alteration in force</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B27-ijms-20-00642" ref-type="bibr" class="xref">27</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-CD</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
     <italic class="italic">Ocimum basilicum</italic>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Swiss mice</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">50 mg/kg</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Anti-inflammatory</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Inhibited leukocyte recruitment to the peritoneal cavity, and inhibited granuloma formation in mice</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B28-ijms-20-00642" ref-type="bibr" class="xref">28</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-CD 
     <break class="break"/>Hydroxypropyl-β-CD
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Oleoresins 
     <italic class="italic">Copaifera multijuga</italic>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Swiss mice</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">100 mg/kg</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Anti-inflammatory</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">This study showed that it is possible to produce inclusion complexes of oleoresins 
     <italic class="italic">Copaifera multijuga</italic>, with CDs by the kneading and slurry methods without any change in anti-inflammatory activity
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B32-ijms-20-00642" ref-type="bibr" class="xref">32</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">SBE-β-CD; 
     <break class="break"/>HP-β-CD
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Valdecoxib</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Mice (S)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">1 mg/kg</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Anti-inflammatory</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Valdecoxib alone showed slow in vivo absorption giving a maximum % inhibition of edema (16%) after a period of 3 h. Valdecoxib included in the cavity of both the CDs showed high absorption rates in vivo, achieving more than 50% inhibition of edema in the 1h and a maximum percentage of inhibition of edema (66%) after a period of 3 h</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B33-ijms-20-00642" ref-type="bibr" class="xref">33</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-CD</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Meloxicam</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Swiss albino mice (20–25 g)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">-</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Antinociceptive</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">A greater percentage inhibition (71.11 ± 1.47%) of the writhing responses was observed with the formulation than with meloxicam alone (45.55 ± 2.05%)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B34-ijms-20-00642" ref-type="bibr" class="xref">34</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">HP-β-CD</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Coumestrol</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Wistar rats</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">10 μM, 50 μM</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Anti-inflammatory</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">The association of 50 μM (66.1%) and 10 μM (56.3%) coumestrol/HP-β-CD induced proliferation and cell migration in inflicted wounds.</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B35-ijms-20-00642" ref-type="bibr" class="xref">35</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-CD</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">(−)-linalool</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Swiss mice</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">40 mg/kg</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Antinociceptive</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Inclusion complexes with linalool/β-CD revealed that the antinociceptive effect was significantly improved when compared with linalool alone</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B36-ijms-20-00642" ref-type="bibr" class="xref">36</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-CD</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Essential oil 
     <italic class="italic">Lippia grata</italic>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Mice (S)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">6, 12, or 24 mg/kg</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Antinociceptive</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Antinociceptive profile might be linked to the presence of some terpenoids, such as camphor, borneol and b-caryophyllene, and to the activation of the motor cortex, nucleus raphe magnus (NRP) and periaqueductal gray (PAG) cerebral areas involved in pain modulation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B37-ijms-20-00642" ref-type="bibr" class="xref">37</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-CD</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">LIN</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Mice (S)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">25 mg/kg (p.o.)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Antihyperalgesic</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">The inclusion complex prolonged the time-effect, possibly by increasing stability and solubility</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B38-ijms-20-00642" ref-type="bibr" class="xref">38</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-CD</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Carvacrol</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Mice (S)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">50 mg/kg (p.o.)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Analgesic</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">The inclusion complex prolonged the time-effect, possibly through increased stability and solubility</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B39-ijms-20-00642" ref-type="bibr" class="xref">39</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-CD</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Hecogenin acetate</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Swiss mice</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">20 mg/kg</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Antinociceptive</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Complexation efficiency of 92%, superior analgesic effect in animal models for orofacial pain at a lower dose when compared to hecogenin alone</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B40-ijms-20-00642" ref-type="bibr" class="xref">40</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-CD</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Hecogenin acetate</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Swiss mice</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">20 mg/kg</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Antihyperalgesic</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Oral pretreatment with hecogenin-CD (HA-CD), produced a significant antinociceptive profile and also decreased mechanical hyperalgesia, with HA-CD showing significantly better effects when compared to HA alone</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B41-ijms-20-00642" ref-type="bibr" class="xref">41</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-CD</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">D-limonene</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Swiss mice</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">50 mg/kg</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Antihyperalgesic</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Longer analgesic duration and reduced Fos protein expression in the dorsal horn of the spinal cord</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B42-ijms-20-00642" ref-type="bibr" class="xref">42</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-CD</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Curcumin</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Mice (S)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">100 mg/kg</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Anticancer</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Curcumin-CDS complexes enhanced curcumin delivery and improved its therapeutic efficacy compared with free curcumin in vivo and in vitro</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B43-ijms-20-00642" ref-type="bibr" class="xref">43</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-CD</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Farnesol</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Swiss mice</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">50 and 100 mg/kg</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Antinociceptive</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Improved pharmacological properties when compared to the active compound alone. Biotechnological value in the treatment of some types of dysfunctional pain such as orofacial pain</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B44-ijms-20-00642" ref-type="bibr" class="xref">44</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-CD</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Essential oil 
     <italic class="italic">Cymbopogon winterianus</italic>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Swiss mice</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">50–200 mg/kg</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Antinociceptive</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">The use of 
     <italic class="italic">C. winterianus</italic> essential oil complexed in CD considerably reduced the dose of 
     <italic class="italic">C. winterianus</italic> contained in the complex when compared to the doses commonly used for the pure 
     <italic class="italic">C. winterianus</italic> described in the literature
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B45-ijms-20-00642" ref-type="bibr" class="xref">45</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-CD</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">LIN</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Mice (S)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">40 mg/kg</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Gastroprotector</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">The complex revealed that the gastroprotective effect was significantly improved compared with uncomplexed linalool, suggesting that this improvement is related to increased solubility and stability</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B46-ijms-20-00642" ref-type="bibr" class="xref">46</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">SBE-β-CD</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Posaconazole</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Sprague–Dawley rats (240 ± 20 g)</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">0.05–4.0 μg/mL</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Intestinal absorption</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">The results demonstrated that the formation of the posaconazole sulfobutylether β-CD inclusion complex significantly improved the bioavailability of posaconazole in comparison with pure posaconazole</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B47-ijms-20-00642" ref-type="bibr" class="xref">47</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">α-CD</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Polyurethane graft</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Male mice of swiss albino strain with average body weight 20–25 g</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">500 μg</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Anticancer</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Efficacy of the sustained release of drug from the graft copolymer without side effects helps suggests a promising novel future drug delivery vehicle for the treatment of melanoma</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B48-ijms-20-00642" ref-type="bibr" class="xref">48</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">SBE-β-CD</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Amlodipine</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Male New Zealand variety rabbit weighing 1.5–2 kg</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">-</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Anti-inflammatory</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Presence of SBE-β-CD in the amlodipine 
     <break class="break"/>Hydroxypropyl Methylcellulose film improved ocular permeation significantly and could be utilized as a mucoadhesive type formulation for anti-inflammatory activity
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B49-ijms-20-00642" ref-type="bibr" class="xref">49</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-CD 
     <break class="break"/>γ-CD
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Limonin</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Wistar rats weighing 200–250 g</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">0.12 mg/kg</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Anti-inflammatory</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Significant reduction of the volume of the paw edema. Administration of limonin was able to reduce the degree of bone resorption, soft tissue swelling and osteophyte formation, improving articular function in treated animals</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B50-ijms-20-00642" ref-type="bibr" class="xref">50</xref>]
    </td>
   </tr>
   <tr class="tr">
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-CD </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Albendazole and ricobendazole</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">BALB/c mice 8-week-old</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">30 mg/kg</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Anticancer</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Solubility was highest when β-CD was used as carrier. This increase in solubility was higher for albendazole, indicating the formation of a more stable complex than with ricobendazole In vivo studies showed that the ABZ:β-CD complex produced a reduction in the tumor growth kinetics on mice with no signs of toxicity</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[
     <xref rid="B51-ijms-20-00642" ref-type="bibr" class="xref">51</xref>]
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
